MKI67 and neoplasm: In recent years, Stalhammar et al. have observed DIA outperforming VDS (with pancytokeratin CkMNF116 and Ki-67) in terms of sensitivity and specificity in differentiating Luminal A and B tumour molecular subtypes, as stratified by Prediction Analysis of Microarray 50 (or PAM50) [142].